US Congressman Presses DOJ, DEA Heads on Cannabis Rescheduling Timeline
The cannabis rescheduling timeline is critical for advancing federal regulation and medical cannabis research. Congressional pressure on DOJ and DEA heads highlights the urgency of this policy shift. This change could remove barriers to clinical trials…
Medicare’s Cannabis (CBD) Coverage Plan Sparks Federal Controversy
Medicare CBD policy access is a critical issue affecting patient care and clinical practice. Federal controversy surrounds cannabis coverage decisions by CMS. This debate impacts access for millions relying on Medicare.
Veteran Faces Career Risk Over Cannabis Shop Involvement
This article discusses veterans military policy legal issues related to cannabis use and employment. It highlights the conflict between state legalization and federal military rules. Veterans face challenges accessing therapeutic cannabis without risking…